Study: Preoperative Chemoradiotherapy Improves Survival of Esophageal Cancer Patients

A new study published in the New England Journal of Medicine reveals that the use of preoperative chemoradiotherapy helps improve survival in patients with potentially curable esophageal or esophagogastric-junction cancer, according to the study’s abstract.

Advertisement
By: Staff

 

Of the 366 patients included in the study, 178 were randomly assigned to chemoradiotherapy followed by surgery while 188 had surgery alone.

 

Median overall survival for the patients in the chemoradiotherapy–surgery group was 49.4 months, more than double the 24.0 month survival for the surgery group.

 

The research was led by Dr. Ate van der Gaast at the department of medical onocology at Erasmus University Hospital in Rotterdam, Netherlands.

 

Related Articles on Cancer:

NB’s Good Samaritan Hospital Wins Colorectal Cancer Screening and Awareness Challenge

Study: Childhood Cancer Survivors at Increased Risk for Gastrointestinal Subsequent Malignant Neoplasms

Cannabinoid Therapy Proves Effective as Cancer Pain Treatment

Advertisement

Next Up in GI & Endoscopy

Advertisement